A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Gene Therapy for Cardiomyopathies
[chapter]
2019
In Vivo and Ex Vivo Gene Therapy for Inherited and Non-Inherited Disorders
Heart disease remains the prevalent cause of premature death and accounts for a significant proportion of all hospital admissions. Molecular genetics was integrated quite late in cardiology, but introduced new concepts like sarcolemmopathies, cytoskeletalopathies, and channelopathies useful to better understand the pathophysiology of the development of inherited cardiomyopathies (CMs). As our understanding of the cellular and molecular processes involved in the development and progression of
doi:10.5772/intechopen.80478
fatcat:bv2xqaducvftpn5szfmiz6b6ta